'FDA panel votes against Capricor's Duchenne heart disease therapy'- Reuters

Benzinga Newsdesk · Jul 29, 2026 ·3 months ago

NewsGeneral

https://www.reuters.com/business/healthcare-pharmaceuticals/fda-panel-votes-against-capricors-duchenne-heart-disease-therapy-2026-07-29/

Read the original